ImmunityBio, Inc.

Each November, #LungCancerAwarenessMonth highlights the importance of education, early detection, and innovation. ImmunityBio is proud to support this awareness by researching new approaches for patients with lung cancer, where significant unmet need remains.

ImmunityBio is heading to #LUGPA2026. We look forward to learning, connecting, and celebrating the strength of independent urology with practice leaders and clinicians. Visit us at booth #712 to connect with our team.

ImmunityBio Medical Affairs leadership will be attending #SITC26, taking place November 4-8 in Phoenix. We're excited to connect with colleagues across the oncology community and take part in conversations advancing cancer immunotherapy. If you're attending, we hope to see you there.

We were honored to join the oncology community at #ESMO26 in Madrid, sharing progress in our mission to harness the power of immunotherapy. The energy and collaboration throughout the week reinforced what drives us: advancing innovative treatments with the goal of improving outcomes and quality of life for patients worldwide. Thank you to our team and collaborators who make this work possible.

Progress in research happens one study at a time. We're committed to transparency in our clinical development programs. Stay informed about where our investigational candidates stand. Check our latest pipeline updates: immunitybio.com/pipeline/

ImmunityBio is excited to attend the European Society for Medical Oncology (ESMO) 2026 Congress in Madrid - a highly influential global oncology meeting bringing together clinicians, researchers, patient advocates, and industry leaders from around the world. #ESMO26 will be a platform for advances in oncology research, clinical practice, and patient care. We look forward to engaging with the global oncology community, exploring impactful new data, and contributing to the future of cancer care on a global scale. @myESMO

We're hiring at our new Dunkirk facility. ImmunityBio is expanding our manufacturing operations and seeking talented professionals in Manufacturing & Operations, QA/QC, Process Engineering, and Regulatory Affairs. Join us in our mission to develop innovative immunotherapies that transform patient outcomes. Apply now: immunitybio.com/careers/

According to the American Cancer Society, lung cancer is the second most common cancer in both men and women in the United States. Through clinical research and collaboration, ImmunityBio is researching medications aiming to help those affected. Learn more about our research and clinical trials: immunitybio.com/non-small-ce…

We're excited to join the World Bladder Cancer Patient Forum 2026 in Hong Kong, bringing together voices from across the globe to advance bladder cancer care and advocacy. Today, ImmunityBio's Anjali Malhotra joined a panel on patient-centric clinical trial design, contributing to an important conversation about putting patients at the center of research. #BladderCancerForum26

On World Lymphoma Awareness Day, we stand with the more than 1 million people worldwide living with lymphoma, including those facing Non-Hodgkin's Lymphoma, the most common form of this disease. At ImmunityBio, we are dedicated to advancing innovative immunotherapy approaches that are being studied for patients with Non-Hodgkin's Lymphoma. Today, we honor the patients, caregivers, and healthcare providers confronting lymphoma every day. Your strength drives our science.

ImmunityBio is expanding our team. We're seeking passionate professionals across research, clinical development, manufacturing, and corporate functions who share our commitment to advancing immunotherapy. Explore open roles: immunitybio.com/careers